Navigation Links
Researchers find new hope for treatment of chronic leukemia
Date:8/17/2011

Wednesday, August 17, 2011, Cleveland: While testing a new drug designed to treat chronic leukemia, researchers at Cleveland Clinic discovered new markers that could identify which patients would receive maximum benefit from the treatment.

This information was released in the online edition of Blood, a weekly medical journal published by the American Society of Hematology.

Chronic lymphocytic leukemia (CLL), a cancer of the white blood cells that is incurable with standard treatment, is the most common type of leukemia in the Western Hemisphere. Conventional chemotherapy is effective at controlling CLL for many years, but the disease always relapses. CLL is characterized by an uncontrolled cell growth and division due to a defect in a process called programmed cell death, or apoptosis. A group of proteins called the Bcl-2 family is responsible for this defect.

Alex Almasan, Ph.D., a researcher in the Lerner Research Institute (LRI) of Cleveland Clinic in close collaboration with other researchers in both LRI and the Taussig Cancer Institute of Cleveland Clinic collected blood samples from patients with CLL and tested the ability of a new drug to kill the cancerous cells. The drug, Navitoclax, is already in early stage clinical testing for patients with CLL. Navitoclax appears to be effective for some patients, and until this research study, there had been no clear way to predict who will respond to its effects.

In addition, these studies can be informative to the currently ongoing clinical trials with Navitoclax in other hematologic malignancies or solid tumors.

"Follow-up studies on patients that have been treated with Navitoclax, particularly those that are poor responders, could determine whether the Bcl-2 family genes examined in this study may also be important for development of resistance to this agent," said Almasan.


'/>"/>

Contact: Dan Doron
dorond@ccf.org
216-312-0428
Lerner Research Institute
Source:Eurekalert

Page: 1

Related biology news :

1. Researchers find way to align gold nanorods on a large scale
2. UBC researchers discover key mechanism that regulates shape and growth of plants
3. Researchers discover oldest evidence of nails in modern primates
4. Researchers map pathway of infection for a common, potentially life-threatening respiratory virus
5. Researchers demonstrate green tea is effective in treating genetic disorder and types of tumors
6. Researchers discover freshwater mussel species thought to be extinct
7. NYU Langone researchers identify a signaling pathway as possible target for cancer treatment
8. Toronto researchers first to discover new genetic clue in the development of rheumatoid arthritis
9. Researchers decode workings of mysterious, but critical TB drug
10. Researchers fight cholera with computer forecasting
11. Vanderbilt researchers, international team, uncover genes linked to multiple sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/11/2020)... , ... March 11, 2020 , ... ... telemedicine company backed by Siemens Healthineers and several healthcare VC firms introduces a ... 100,000 people in over 100 countries and has caused over 4,000 fatalities to ...
(Date:3/5/2020)... ... March 05, 2020 , ... ... partnership agreement with Phoenestra GmbH to accelerate Cytonus’ existing products and to expand ... Diego, California. Phoenestra is a biotech company located in Austria. , Phoenestra ...
(Date:3/5/2020)... ... March 05, 2020 , ... In September 2016, stem cell ... Test™ is the first, and still only, available technology that provides the cell-specific ... provide information about the number and quality of therapeutic tissue stem cells are ...
Breaking Biology News(10 mins):
(Date:3/4/2020)... , ... March 04, 2020 , ... This month, Cognosante ... Orlando, FL. The company will showcase both expanded and emerging offerings that align with ... 2020 is designed to be comprehensive, timely, and engaging. From Interoperability ...
(Date:3/2/2020)... ... March 02, 2020 , ... McBee, Moore and Vanik IP, LLC ... the field of Biotechnology and Organics. , According to statistics compiled by Harrity Anaytics, ... patents issued in technology center 1600 during 2019. Technology center 1600 at the US ...
(Date:2/21/2020)... ... February 20, 2020 , ... In a free ... speakers from Synteract including Lisa Dilworth, BS, MS, Vice President Rare, Orphan ... challenges, with feasible strategies and solutions to support patients, sites and sponsors. , When ...
(Date:2/21/2020)... ... February 21, 2020 , ... Join Forrest Brown, Engineering Services Manager – ... Inc. for an informative session on Wednesday, February 26, 2020 at ... to incorporate into facility design to add manufacturing flexibility in the future, especially for ...
Breaking Biology Technology: